The store will not work correctly when cookies are disabled.
1-(4-(4-fluorophenyl)-2-methyl-1-(p-tolyl)-1H-pyrrol-3-yl)ethan-1-one
ID: ALA5266795
Max Phase: Preclinical
Molecular Formula: C20H18FNO
Molecular Weight: 307.37
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)c1c(-c2ccc(F)cc2)cn(-c2ccc(C)cc2)c1C
Standard InChI: InChI=1S/C20H18FNO/c1-13-4-10-18(11-5-13)22-12-19(20(14(22)2)15(3)23)16-6-8-17(21)9-7-16/h4-12H,1-3H3
Standard InChI Key: ZYEIAXGIGYEYCZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
-1.8923 1.3688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1778 0.9563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4246 1.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1271 0.6789 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2851 -0.0351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0916 0.1363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2112 2.0880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6062 0.9566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8923 2.1932 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9516 0.6789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3640 1.3928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1859 1.3921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5983 0.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1895 -0.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3656 -0.0380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4228 0.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6746 -0.4466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4614 -1.2431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0432 -1.8237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8398 -1.6103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0537 -0.8182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4744 -0.2323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4228 -2.1932 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 2 1 0
3 7 1 0
1 8 1 0
1 9 2 0
10 4 1 0
11 10 2 0
12 11 1 0
13 12 2 0
14 13 1 0
10 15 1 0
15 14 2 0
13 16 1 0
17 6 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
17 22 1 0
22 21 2 0
20 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 307.37 | Molecular Weight (Monoisotopic): 307.1372 | AlogP: 5.10 | #Rotatable Bonds: 3 |
Polar Surface Area: 22.00 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.00 | CX LogD: 5.00 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.62 | Np Likeness Score: -0.94 |
References
1. Kumar G, Kiran Tudu A.. (2023) Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors., 80 [PMID:36731248] [10.1016/j.bmc.2023.117187] |